| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2810734 | Trends in Endocrinology & Metabolism | 2010 | 7 Pages |
Abstract
The multi-ligand Receptor for Advanced Glycation Endproducts (RAGE) is expressed in podocytes and endothelial cells in the human and murine glomerulus. Although present at low levels in homeostasis, RAGE expression is increased during disease. Pharmacological antagonism of RAGE or its genetic deletion imparts marked protection from podocyte effacement, albuminuria and glomerular sclerosis in disease models. In human subjects, associations between specific genetic polymorphisms of RAGE and levels of soluble forms of RAGE are linked to disease states in the kidney. In this review, we summarize the evidence from mouse to man, linking RAGE to the pathogenesis of nephropathy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Vivette D’Agati, Shi Fang Yan, Ravichandran Ramasamy, Ann Marie Schmidt,